The Supreme Court Ruling on Gene Patentability: How the Myriad Genetics Ruling Affects the Future of Biotechnology

The Supreme Court Ruling on Gene Patentability: How the Myriad Genetics Ruling Affects the Future of Biotechnology

Barnes & Thornburg is making this complimentary video conference available in the Columbus Office.

While the Supreme Court's decision offers urgently-needed certainty for research-driven companies that rely on cDNA patents for investment in innovation, it could also unnecessarily create business uncertainty for a broader range of biotechnology inventions.

At least 8,000 currently existing patents will be affected by this decision and the companies who will be most likely impacted are small operations who rely upon the strength of their intellectual property to secure funding for additional research.

How murky is the path ahead and what strategies should you be considering to keep your plans on track?

Lunch will be provided.